Skip to main content

Table 1 The patient demographic data and the dose of insulin for 101 type 1 diabetic patients on basal-bolus insulin therapy as stratified equally by HbA1c value

From: The relationship between HbA1c values and the occurrence of hypoglycemia as assessed by continuous glucose monitoring in patients with type 1 diabetes

HbA1c Group A
HbA1c ≤7.2 %
Group B
7.2 % <HbA1c ≤8.2 %
Group C
8.2 % <HbA1c ≤9.2 %
Group D
HbA1c >9.2 %
P value
Males
/femalesa
5/19 8/18 10/17 9/15 0.518
Age
(years)b
36.5
(32.0–58.8)
41.5
(31.5–54.5)
41.0
(32.0–55.0)
42.0
(35.0–57.8)
0.956
Duration of diabetes
(years)b
11.0
(5.3–30.0)
15.0
(7.8–25.5)
15.0
(5.0–24.0)
10.5
(7.3–15.0)
0.653
BMI
(kg/m2)b
20.3
(18.2–22.3)
22.6
(21.0–24.9)
22.4
(20.0–23.8)
22.2
(20.3–25.3)
0.007
U-CPR
(µg/day)b
1.2
(0.9–3.9)
0.9
(0.6–2.6)
1.3
(0.7–3.6)
1.0
(0.5–6.0)
0.622
Total daily dose of insulin (units)b 31.0
(25.5–38.8)
35.0
(26.5–41.5)
37.0
(29.0–46.0)
39.0
(31.3–51.5)
0.099
Basal insulin dose (units)b 13.5
(9.3–19.5)
14.0
(10.0–20.3)
15.0
(12.0–18.0)
18.5
(14.0–24.8)
0.021
Bolus insulin dose (units)b 17.0
(15.0–24.0)
19.5
(15.0–24.3)
20.0
(16.0–30.0)
21.5
(13.8–27.5)
0.296
  1. Data presented as median (25–75 percentiles)
  2. Italic values indicate significance of P value (P < 0.05)
  3. aChi square test
  4. bKruskal–Wallis test